- Report
- March 2026
- 150 Pages
Global
From €3399EUR$3,750USD£2,896GBP
- Report
- June 2026
- 135 Pages
Global
From €2718EUR$2,999USD£2,316GBP
€3625EUR$3,999USD£3,088GBP
- Report
- April 2026
- 145 Pages
Global
From €2718EUR$2,999USD£2,316GBP
€3625EUR$3,999USD£3,088GBP
- Report
- April 2026
- 149 Pages
Global
From €2718EUR$2,999USD£2,316GBP
€3625EUR$3,999USD£3,088GBP
- Report
- April 2026
- 180 Pages
Global
From €4306EUR$4,750USD£3,668GBP
- Report
- July 2025
- 350 Pages
Global
From €4486EUR$4,949USD£3,822GBP
- Report
- October 2025
- 160 Pages
Global
From €2864EUR$3,160USD£2,440GBP
€3581EUR$3,950USD£3,050GBP
- Report
- August 2025
- 150 Pages
Global
From €2864EUR$3,160USD£2,440GBP
€3581EUR$3,950USD£3,050GBP
- Report
- March 2026
- 219 Pages
Global
From €4396EUR$4,850USD£3,746GBP
- Report
- September 2025
- 150 Pages
Global
From €4396EUR$4,850USD£3,746GBP
- Report
- August 2025
- 150 Pages
Global
From €4396EUR$4,850USD£3,746GBP
- Report
- February 2026
- 199 Pages
Global
From €4528EUR$4,995USD£3,858GBP
- Report
- February 2026
- 193 Pages
Global
From €4528EUR$4,995USD£3,858GBP
- Report
- April 2026
- 160 Pages
Global
From €3009EUR$3,320USD£2,564GBP
€3762EUR$4,150USD£3,205GBP
- Report
- April 2026
- 160 Pages
Global
From €3009EUR$3,320USD£2,564GBP
€3762EUR$4,150USD£3,205GBP
- Report
- January 2026
- 160 Pages
Global
From €2864EUR$3,160USD£2,440GBP
€3581EUR$3,950USD£3,050GBP
- Report
- September 2025
- 150 Pages
Global
From €4034EUR$4,450USD£3,437GBP
- Report
- March 2026
- 157 Pages
Global
From €3500EUR$4,136USD£3,086GBP
- Report
- October 2025
- 150 Pages
Global
From €4396EUR$4,850USD£3,746GBP
- Report
- January 2026
- 172 Pages
Global
From €4487EUR$4,950USD£3,823GBP

Inhalers and nebulisers are medical devices used to deliver medication to the lungs. Inhalers are handheld devices that deliver medication in the form of a mist or aerosol, while nebulisers are larger machines that deliver medication in the form of a fine mist. Inhalers are the most common form of medication delivery for respiratory conditions such as asthma and COPD.
Inhalers and nebulisers are used by millions of people around the world, and the market for these devices is highly competitive. Companies in the market are constantly innovating to develop new and improved devices that are more effective and easier to use. Many of these devices are now available over the counter, making them more accessible to patients.
The inhaler market is also highly regulated, with governments and health authorities setting standards for the safety and efficacy of these devices. Companies must adhere to these standards in order to remain competitive.
Some of the major companies in the inhaler market include GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Novartis, Merck, and Teva Pharmaceuticals. Show Less Read more